Table 1.
Patient information: University of Kentucky Brain Bank
| Label | Age | Gender | Brain weight (g) |
PMI (h) | Braak stage |
CERAD plaque density |
Diagnosis | APOE alleles |
RIN |
|---|---|---|---|---|---|---|---|---|---|
| G1 | 75 | F | 1330 | 3.50 | 1 | None | Normal (no amyloid) | 3/3 | 7.1 |
| G2 | 84 | F | 1100 | 2.50 | 1 | None | Normal (no amyloid) | 3/3 | 8.1 |
| E1 | 37 | F | 760 | 3.50 | 0 | None | FTLD (TDP43 negative) | 3/3 | 5.5 |
| F1 | 53 | F | 940 | 4.75 | 2 | Mod | FTLD (TDP43 positive) | – | 7.9 |
| E2 | 48 | M | 900 | 3.75 | 0 | None | FTLD (TDP43 positive) | – | 5.3 |
| F2 | 87 | F | 970 | 4.50 | 0 | Low | FTLD (TDP43 positive) | – | 7.8 |
| D1 | 70 | M | 1240 | 3.00 | 1 | None | Progressive supranuclear palsy | 3/3 | 8.3 |
| C4 | 84 | F | 1090 | 3.00 | 2 | None | Bilateral hippocampal sclerosis | – | 8.9 |
| C3 | 84 | F | 870 | 1.75 | 1 | None | Bilateral hippocampal sclerosis | 2/3 | 8.8 |
| C2 | 93 | M | 1170 | 2.75 | 3 | Mod | Bilateral hippocampal sclerosis + Alzheimer changes | 3/4 | 8.6 |
| C1 | 101 | F | 1070 | 2.25 | 5 | None | Bilateral hippocampal sclerosis | 3/3 | 9 |
| B4 | 78 | M | 1270 | 3.75 | 1 | Low | Dementia with Lewy bodies | 3/4 | 8.3 |
| B3 | 78 | M | 1240 | 2.50 | 1 | None | Dementia with Lewy bodies | 3/3 | 8.1 |
| B2 | 85 | F | 1080 | 2.00 | 2 | High | Dementia with Lewy bodies | 2/3 | 8.9 |
| B1 | 68 | M | 1380 | 3.75 | 2 | Mod | Dementia with Lewy bodies | 3/4 | 5 |
| A5 | 83 | F | 1160 | 2.25 | 5 | High | Braak V Alzheimer | 3/4 | 8.4 |
| A1 | 86 | F | 1010 | 2.00 | 6 | High | Braak VI Alzheimer | 3/3 | 5.3 |
| A2 | 67 | F | 790 | 2.25 | 6 | High | Braak VI Alzheimer | 3/4 | 6.5 |
| A3 | 75 | F | 1050 | 2.50 | 6 | High | Braak VI Alzheimer | 3/4 | 7.9 |
| A4 | 86 | F | 1030 | 2.75 | 6 | High | Braak VI Alzheimer | 3/4 | 7.4 |